Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer. - Wikidata - awgldk - TriplyDB

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

http://www.wikidata.org/entity/Q33366682

about

Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancer Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer.Hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil or oral S-1 improves the prognosis of patients with postoperative liver metastases from pancreatic cancer.Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer.A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study.Pancreatic cancer: a review of recent advances.A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer.Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer.

P2860

Q26786174-7B0563C5-FD7A-4558-B1A8-7C7CF9D017C1 Q33371306-5671C2BB-A43D-4BE7-BC89-5A51B13DF6E6 Q33403255-3099EBE2-0523-40B2-8284-738395EBDC95 Q33412001-F718A74E-8DC1-4F86-A340-DC0A653B5A3C Q33414074-187056CA-60F2-461B-BBDF-EB6A11D3F0D0 Q33728782-91FD3BCE-6C76-41E7-A1ED-6AE495829C9D Q36072772-214F0078-ABFA-425C-B023-A6311638E100 Q36623071-EE696481-8EEE-44EA-8953-D0278EB291BB Q37559761-513DA792-2C9D-4002-80A0-BCF3C5ECD37B Q44664897-F0A5AB06-1CFA-46D7-9368-01E4C3E4529F

P2860

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

http://www.wikidata.org/entity/Q33366682

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

@ast

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

@en

type

label

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

@ast

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

@en

prefLabel

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

@ast

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

@en

P1433

Q33366682-2C103F02-CB57-4DEA-97B9-CA577343C38A

P1476

Q33366682-AFE26242-9788-4817-8C52-4A17863B9FED

P2093

Q33366682-1A1D8843-AA3B-4160-B944-F6D061C15893

Q33366682-2C14B433-1222-4C39-B59A-66E0869F2950

Q33366682-338E2590-6EF9-407B-9DF6-84D3D26D7C05

Q33366682-61489D07-E06C-4CC0-8C17-1644CF45BE36

Q33366682-B3F182DC-062B-4BBF-A198-78B720FCC00B

Q33366682-DFC4C887-A357-4145-96AC-A21907F6486D

Q33366682-F948FD00-D803-40DA-B6CF-32EDD08CD0A0

Q33366682-FA670AE4-BBAF-4DC2-AB2E-53FFCFAFAFB3

P2860

Q33366682-09CE2914-5E6E-411B-BB12-16BFC744E443

Q33366682-17772339-0423-48AE-98D5-86118F2A81CF

Q33366682-2417D161-EBC9-475E-B0C3-47921C427D75

Q33366682-3C72C898-9139-4B80-8661-159D089BB82E

Q33366682-46A4573A-DD6E-4DEB-8EE9-05263CB3E985

Q33366682-760B1A22-B2E6-47A7-B029-B956A13A9903

Q33366682-77FA2C09-DDA4-49DA-A396-4010237B5A94

Q33366682-B5648809-ACE0-4BA1-9436-33BA2DDC7743

Q33366682-C423D246-21E9-44FC-94E4-1C98ED7D55CD

Q33366682-C674DFBF-E3B1-46CC-B42E-44A821E750AE

P2888

Q33366682-693CC64A-CBC3-45A6-A4B1-FBC23993B4E4

P304

Q33366682-95BE8E42-E0E9-4BB4-A764-CF211EC28BA1

P31

Q33366682-12FBEB6A-81AE-4441-91B8-9ED76947605F

P356

Q33366682-89E89DC7-EAAC-47F4-9E69-E54C3B7905BE

P407

Q33366682-FE8F8064-7FB5-4AAE-8A27-1C01F43C8D75

P433

Q33366682-1BDF953F-F289-493E-A14B-85E5AE3D710E

P478

Q33366682-633BD2CC-E47A-423E-B33B-8AFFF5F93E4F

P577

Q33366682-A63EAFFE-A740-409A-A1E0-F5A8FE904FC9

P5875

Q33366682-FBB75A59-7951-47E2-AF54-6C5BAC66BE01

P6179

Q33366682-E9A7E0FC-561D-4D67-A994-DE3FEFE36710

P698

Q33366682-994332FA-0249-48B5-841D-F47D48EA74EC

P921

Q33366682-2B3FCCD6-F8A1-4601-B362-92FA953C673B

P932

Q33366682-5B19417D-33FE-4900-A68E-1240D7391CA5

P356

P1433

British Journal of Cancer

P1476

Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

@en

P2093

A Kobayashi

http://www.w3.org/2001/XMLSchema#string

H Kato

http://www.w3.org/2001/XMLSchema#string

H Saisho

http://www.w3.org/2001/XMLSchema#string

H Tadenuma

http://www.w3.org/2001/XMLSchema#string

K Nakamura

http://www.w3.org/2001/XMLSchema#string

K Sudo

http://www.w3.org/2001/XMLSchema#string

T Ishihara

http://www.w3.org/2001/XMLSchema#string

T Yamaguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.

A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

[Late phase II study of S-1 in patients with advanced head and neck cancer].

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.

Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.

Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).

Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study.

Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer.

P2888

P304

2134-2139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602644

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7799010

http://www.w3.org/2001/XMLSchema#string

P6179

1050549645

http://www.w3.org/2001/XMLSchema#string

P698

15942632

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

2361829

http://www.w3.org/2001/XMLSchema#string